Home/Filings/4/A/0001276591-16-000024
4/A//SEC Filing

HANSEN MEDICAL INC 4/A

Accession 0001276591-16-000024

CIK 0001276591operating

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:32 PM ET

Size

24.5 KB

Accession

0001276591-16-000024

Insider Transaction Report

Form 4/AAmended
Period: 2015-05-26
Vance Cary Guy
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2015-05-26+5,96213,462 total
  • Exercise/Conversion

    Common Stock

    2015-06-01+1,49113,090 total
  • Sale

    Common Stock

    2015-09-17$5.60/sh548$3,06913,597 total
  • Sale

    Common Stock

    2015-06-26$8.70/sh436$3,79312,654 total
  • Exercise/Conversion

    Common Stock

    2015-09-01+1,49114,145 total
  • Exercise/Conversion

    Common Stock

    2015-12-02+1,49115,088 total
  • Sale

    Common Stock

    2015-12-02$2.98/sh491$1,46314,597 total
  • Sale

    Common Stock

    2015-06-24$9.60/sh1,863$17,88511,599 total
  • Exercise/Conversion

    Restricted Stock Unit

    2015-05-26+5,96217,887 total
    Common Stock (5,962 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2015-06-01+1,49116,396 total
    Common Stock (1,491 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2015-09-01+1,49114,905 total
    Common Stock (1,491 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2015-12-02+1,49113,414 total
    Common Stock (1,491 underlying)
Footnotes (8)
  • [F1]Date amended to correct release and settlement dates.
  • [F2]All amounts on this Form 4 reflect the Company's reverse ten-for-one stock split effected on September 22, 2015.
  • [F3]This amendment updates the Amount of Securities Beneficially Owned column to reflect Mr. Vance's holdings in post-reverse stock split amounts. The Form 4 filed on February 4, 2016 that this Form 4/A amends inaccurately reported the Amount of Securities Beneficially Owned in pre-reverse stock split amounts.
  • [F4]Pursuant to Mr. Vance's Restricted Stock Unit Award, the securities disposed of represent shares sold to satisfy withholding obligations in connection with the settlement of vested restricted stock units.
  • [F5]Each restricted stock unit represents the contingent right to receive one share of Common Stock upon vesting of the unit.
  • [F6]The first 25% of the units vested on June 1, 2015. The remaining 75% of the units are scheduled to vest in increments of 6.25% on each March 1, June 1, September 1 and December 1 thereafter, assuming continued employment through the applicable vesting dates.
  • [F7]The units will be forfeited and cancelled to the extent that they have not vested before termination of employment.
  • [F8]This amendment updates the Number of derivative Securities Beneficially Owned Following Reported Transactions in post-reverse stock split amounts. The Form 4 filed on February 4, 2016 that this Form 4/A amends inaccurately reported the Number of derivative Securities Beneficially Owned Following Reported Transactions in pre-reverse stock split amounts.

Issuer

HANSEN MEDICAL INC

CIK 0001276591

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001276591

Filing Metadata

Form type
4/A
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:32 PM ET
Size
24.5 KB